Pimavanserin
Overview
Pimavanserin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2111101).
API suppliers (1)
Suppliers of Pimavanserin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Pimavanserin expires 27 Feb 2039 and exclusivity 27 Oct 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea
- Canonical SMILES
- CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C
- InChIKey
- RKEWSXXUOLRFBX-UHFFFAOYSA-N
Do you supply Pimavanserin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.